PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.
Han T, Xiang DM, Sun W, Liu N, Sun HL, Wen W, Shen WF, Wang RY, Chen C, Wang X, Cheng Z, Li HY, Wu MC, Cong WM, Feng GS, Ding J, Wang HY.
Han T, et al. Among authors: wen w.
J Hepatol. 2015 Sep;63(3):651-60. doi: 10.1016/j.jhep.2015.03.036. Epub 2015 Apr 9.
J Hepatol. 2015.
PMID: 25865556